The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, September 21, 2022
Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied its petition to rehear the negative decision regarding the...
read more
Wednesday, September 14, 2022
Following their recent expansion into formulation, method and lyo development, Berkshire Sterile Manufacturing (BSM) now offers two new services to ...
read more
Sartorius agreed to acquire Albumedix from private investors. The Nottingham, UK-based company provides recombinant albumin-based solutions.
read more
Novavax announced the initiation of its Phase 2b/3 Hummingbird™ clinical trial. The trial will evaluate the safety, effectiveness (immunogenicity), ...
read more
3M announced a spin off of its Health Care business. This results in two world-class public companies positioned to pursue distinct growth plans. The ...
read more
Soleo Health is now a limited distribution partner for the cardiovascular drug LEQVIO®, manufactured by Novartis.
read more
PTI – Packaging Technologies & Inspection, a New York-based solutions provider of package testing equipment, acquired St. Prex, Switzerland based ...
read more
The Canadain Government has signed a new contract with GlaxoSmithKline to support sustained influenza pandemic readiness.
read more
Vi-Jon, LLC is expanding its voluntary recall to include all lots of Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor, 10 FL OZ (296 mL) ...
read more
CEPI, the Coalition for Epidemic Preparedness Innovations, and Codiak BioSciences announced the latest funding award under CEPI’s US $200m program to ...
read more
Boehringer Ingelheim, Evotec SE, and bioMérieux, have formed a joint venture to create the next generation of antimicrobials along with actionable ...
read more
Ionis Pharmaceuticals, Inc. announced that the FDA has granted orphan drug designation and rare pediatric disease designation to ION582, an ...
read more
Valneva SE announced the successful completion of the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The final ...
read more
Biohaven Pharmaceutical Holding Company Ltd. announced that the FDA has filed and accepted for review a New Drug Application (NDA) for zavegepant ...
read more
Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. announced that the companies have entered into a definitive agreement under which Pfizer ...
read more